FDA Takes Ethics Into Its Own Hands; Foreign Trials Now Subject To Only GCP

FDA is revising its policy on accepting trials conducted abroad, replacing language concerning protections for human subjects to require that firms follow Good Clinical Practice standards instead of adhering to the Declaration of Helsinki